Wells Fargo & Company AVADEL PHARMACEUTICALS PLC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
91,444
Previous 84,141 8.68%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
7,303 Added 8.68%
91,444 $0
Q1 2025

May 13, 2025
BUY
N/A
974 Added 1.17%
84,141 $0
Q4 2024

Feb 12, 2025
BUY
N/A
9,719 Added 13.23%
83,167 $0
Q3 2024

Nov 13, 2024
SELL
N/A
-14,624 Reduced 16.6%
73,448 $0
Q2 2024

Aug 13, 2024
BUY
N/A
88,072 New
88,072 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email